Intensive Session: New Approaches to Medical Issues in Long-Term Care

Journal of the American Medical Directors Association

Volumn 8, Issue 7, 2007, Pages 421-433

  Messinger Rapport, Barbara J ^a   Morley, John E ^b,c   Thomas, David R ^b   Gammack, Julie K ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

clostridium; diabetes; Falls; hypertension; pressure ulcers

Indexed keywords

ACARBOSE; ALFACALCIDOL; BAYETTA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; COLECALCIFEROL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ERGOCALCIFEROL; EXENDIN 4; HYDRALAZINE; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; ISOSORBIDE; METFORMIN; MULTIVITAMIN; NEUROLEPTIC AGENT; PERINDOPRIL; PIOGLITAZONE; PLACEBO; QUINOLONE DERIVATIVE; RETINOL; SEROTONIN UPTAKE INHIBITOR; SITAGLIPTIN; SPIRONOLACTONE; SULFONYLUREA; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D;

ADD ON THERAPY; ADMINISTRATIVE PERSONNEL; ANEMIA; ANOREXIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; DECUBITUS; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; FALLING; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HEMATOCRIT; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; INSOMNIA; LONG TERM CARE; LOW DRUG DOSE; MONOTHERAPY; NUTRITION; ORGANIZATION; PHYSICIAN; SIDE EFFECT; WEIGHT REDUCTION;

EID: 34548426046     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2007.07.002     Document Type: Article

References (173)

1. Morley J.E., Thomas D.R., and Gammack J.K. The medical director, JAMDA, and the twenty-first century. J Am Med Dir Assoc 8 (2007) 65-67
2. Heart Failure Society of America. Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 1 (2006) 10-38
3. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 112 (2005) e154-e235
4. Cleland J.G.F., Tendera M., Adamus J., et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27 19 (2006) 2338-2345
5. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 9386 (2003) 777-781
6. Ahmed A., Rich M.W., Love T.E., et al. Digoxin and reduction in mortality and hospitalization in heart failure: A comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 2 (2006) 178-186
7. Ahmed A., Rich M.W., Fleg J.L., et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114 5 (2006) 397-403
8. Flather M.D., Yusuf S., Kober L., et al., ACE-Inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 355 9215 (2000) 1575-1581
9. Flather M.D., Shibata M.C., Coats A.J.S., et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 3 (2005) 215-225
10. Anonymous. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 78 8 (1996) 902-907
11. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 10 (1999) 709-717
12. Juurlink D.N., Mamdani M.M., Lee D.S., et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351 6 (2004) 543-551
13. Ko D.T., Juurlink D.N., Mamdani M.M., et al. Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. J Card Fail 12 3 (2006) 205-210
14. Cohn J.N., Archibald D.G., Ziesche S., et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314 24 (1986) 1547-1552
15. Cohn J.N., Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 5 (1991) 303-310
16. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 20 (2004) 2049-2057
17. Heaney R.P., Dowell M.S., Hale C.A., and Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22 2 (2003) 142-146
18. Peterlik M., and Cross H.S. Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res 26 4A (2006) 2581-2588
19. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81 3 (2006) 353-373
20. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., et al. Effect of vitamin D on falls: A meta-analysis. JAMA 291 16 (2004) 1999-2006
21. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., and Dawson-Hughes B. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293 18 (2005) 2257-2264
22. Spina C.S., Tangpricha V., Uskokovic M., Adorinic L., Maehr H., and Holick M.F. Vitamin D and cancer. Anticancer Res 26 4A (2006) 2515-2524
23. US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans. 6th ed. (2005), US Government Printing Office, Washington, DC 9. http://www.health.gov/dietaryguidelines/dga2005/document/pdf/DGA2005.pdf Available at: http://www.health.gov/dietaryguidelines/dga2005/document/pdf/DGA2005.pdf. Accessed June 25, 2007.
24. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., and Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84 1 (2006) 18-28
25. Drinka P.J., Krause P.F., Nest L.J., and Goodman B.M. Determinants of vitamin D levels in nursing home residents. J Am Med Dir Assoc 8 2 (2007) 76-79
26. Hamid Z., Riggs A., Spencer T., Redman C., and Bodenner D. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc 8 2 (2007) 71-75
27. Rapuri P.B., Gallagher J.C., Kinyamu H.K., and Ryschon K.L. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74 5 (2001) 694-700
28. Ybarra J., Sanchez-Hernandez J., and Perez A. Hypovitaminosis D and morbid obesity. Nurs Clin North Am 42 1 (2007) 19-27
29. Carlin A.M., Rao D.S., Yager K.M., Genaw J.A., Parikh N.J., and Szymanski W. Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis 2 6 (2006) 638-642
30. Johnson R.M., Smiciklas-Wright H., Soucy I.M., and Rizzo J.A. Nutrient intake of nursing-home residents receiving pureed foods or a regular diet. J Am Geriatr Soc 43 4 (1995) 344-348
31. Morley J.E. Should all long-term care residents receive vitamin D?. J Am Med Dir Assoc 8 (2007) 69-70
32. Anonymous. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 49 5 (2001) 664-672
33. American Medical Directors Association (AMDA). Falls and fall risk (2003), National Guideline Clearinghouse, Columbia, MD
34. Bischoff-Ferrari H.A., Orav E.J., and Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: A 3-year randomized controlled trial. Arch Intern Med 166 4 (2006) 424-430
35. Flicker L., MacInnis R.J., Stein M.S., et al. Should older people in residential care receive vitamin D to prevent falls?. Results of a randomized trial. J Am Geriatr Soc 53 11 (2005) 1881-1888
36. Broe K.E., Chen T.C., Weinberg J., Bischoff-Ferrari H.A., Holick M.F., and Kiel D.P. A higher dose of vitamin D reduces the risk of falls in nursing home residents: A randomized, multiple-dose study. J Am Geriatr Soc 55 2 (2007) 234-239
37. Artz A.S., Fergusson D., Drinka P.J., et al. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr 39 3 (2004) 201-206
38. Artz A.S., Fergusson D., Drinka P.J., et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc 52 3 (2004) 423-427
39. Furuland H., Linde T., Ahlmen J., Christensson A., Strombom U., and Danielson B.G. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant 18 2 (2003) 353-361
40. Dharmarajan T.S., and Norkus E.P. Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc 5 6 (2004) 395-400
41. US Food and Drug Administration. FDA strengthens safety information for erythropoiesis-stimulating Agents (ESAs). P07-40 (2007), US Department of Health and Human Services, Washington DC
42. Hayashi K., Hasegawa K., and Kobayashi S. Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin. Kidney Int 60 5 (2001) 1910-1916
43. Ishani A., Weinhandl E., Zhao Z., et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 45 3 (2005) 391-399
44. Ensrud K.E., Blackwell T.L., Mangione C.M., et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 50 10 (2002) 1629-1637
45. Reynolds III C.F., Dew M.A., Pollock B.G., et al. Maintenance treatment of major depression in old age. N Engl J Med 354 11 (2006) 1130-1138
46. Taylor J.A., Parmelee P., Brown H., et al. A model quality improvement program for the management of falls in nursing homes. J Am Med Dir Assoc 8 3 Suppl (2007) S26-S36
47. Vu M.Q., Weintraub, and Rubenstein L.Z. Falls in the nursing home: Are they preventable?. J Am Med Dir Assoc 7 3 Suppl (2006) S53-S58
48. Morley J.E. Falls-where do we stand?. Mo Med 104 (2007) 63-67
49. Iwanczyk L., Weintraub N.T., and Rubenstein L.Z. Orthostatic hypotension in the nursing home setting. J Am Med Dir Assoc 7 (2006) 163-167
50. Flaherty J.H., and Morley J.E. Delirium: A call to improve current standards of care. J Gerontol A Biol Sci Med Sci 59 (2004) 341-343
51. Flaherty J.H., Rudolph J., Shay K., et al. Delirium is a serious and under-recognized problem: Why assessment of mental status should be the 6th vital sign. J Am Med Dir Assoc 8 (2007) 273-275
52. Kim M.J., Rolland Y., Cepeda O., Gammack J.K., and Morley J.E. Diabetes mellitus in older men. Aging Male 9 (2006) 139-147
53. Morley J.E. Diabetes mellitus: A major disease of older persons. J Gerontol A Biol Sci Med Sci 55 (2000) M255-M256
54. Mooradian A.D., Perryman K., Fitten J., et al. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch Intern Med 148 (1988) 2369-2372
55. Sinclair A.J., Girling A.J., and Bayer A.J. Cognitive dysfunction in older subjects with diabetes mellitus: Impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 50 (2000) 203-212
56. Haas L. Management of diabetes mellitus medications in the nursing home. Drugs Aging 22 (2005) 209-218
57. Miller D.K., Lui L.Y., Perry III H.M., et al. Reported and measured physical functioning in older inner-city diabetic African Americans. J Gerontol A Biol Sci Med Sci 54 (1999) M230-M236
58. Rosenthal M.J., Fajardo M., Gilmore S., Morley J.E., and Naliboff B.D. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study. Diabetes Care 21 (1998) 231-235
59. Morley G.K., Mooradian A.D., Levine A.S., and Morley J.E. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med 77 (1984) 79-82
60. Stratton I.M., Cull C.A., Adler A.I., Matthews D.R., Neil H.A., and Holman R.R. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: A prospective observational study (UKPDS 75). Diabetologia 49 (2006) 1761-1769
61. Wedick N.M., Barrett-Connor E., Knoke J.D., and Wingard D.L. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: The Rancho Bernardo study. J Am Geriatr Soc 50 (2002) 1810-1815
62. Morley J.E., and Silver A.J. Nutritional issues in nursing home care. Ann Intern Med 123 (1995) 850-859
63. Coulston A.M., Mandelbaum D., and Reaven G.M. Dietary management of nursing home residents with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 51 (1990) 67-71
64. Tariq S.H., Karcic E., Thomas D.R., et al. The use of no-concentrated-sweets diet in the management of type 2 diabetes in nursing homes. J Am Diet Assoc 101 (2001) 1463-1466
65. American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 23 Suppl 1 (2000) S43-S46
66. Niedert K.C., and American Dietetic Association. Position of the American Dietetic Association: Liberalization of the diet prescription improves quality of life for older adults in long-term care. J Am Diet Assoc 105 (2005) 1955-1965
67. Morley J.E. An overview of diabetes mellitus in older persons. Clin Geriatr Med 15 (1999) 211-224
68. Mazza A.D., and Morley J.E. Metabolic syndrome and the older male population. Aging Male 10 (2007) 3-8
69. Morley J.E. The elderly Type 2 diabetic patient: Special consideration. Diabet Med 15 Suppl 4 (1998) S41-S46
70. Lee A., and Morley J.E. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 6 (1998) 47-53
71. Crandall J., Schade D., Ma Y., et al., Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 61 (2006) 1075-1081
72. Herman G.A., Stein P.P., Thornberry N.A., and Wagner J.A. Dipeptidyl peptidase-4 inhibitors for the treatment of Type 2 diabetes: Focus on sitagliptin. Clin Pharmacol Ther 81 (2007) 761-767
73. Rosenstock J., Baron M.A., Dejager S., Mills D., and Schweizer A. Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: A 24-week, double-blind, randomized trial. Diabetes Care 30 (2007) 217-223
74. Lyseng-Williamson K.A. Sitagliptin. Drugs 67 (2007) 587-597
75. Dejager S., Razac S., Foley J.E., and Schweizer A. Vildagliptin in drug-naïve patients with Type 2 diabetes: A 24-week, double-blind, randomized, placebo-controlled, multiple-dose study. Horm Metab Res 39 (2007) 218-223
76. Lee A., Patrick P., Wishart J., et al. The effects of miglitol on glucagon-like peptide1 secretion and appetite sensations in obese type 2 diabetes. Diabetes Obes Metab 4 (2002) 329-335
77. DeLeon M.J., CHandurkar V., Albert S.G., and Mooradian A.D. Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects. Diabetes Res Clin Pract 56 (2002) 101-106
78. Genvois P., Fruchart J.C., and Staels B. Drug insight: Mechanisms of action and therapeutic applications for agonists of peroxisome proliferators-activated receptors. Nat Clin Pract Endocrinol Metab 3 (2007) 145-156
79. Zarowitz B.J., Tangalos E.G., Hollenack K., and O'Shea T. The application of evidence-based principles of care in older persons (issue 3): Management of diabetes mellitus. J Am Med Dir Assoc 7 (2006) 234-240
80. Granberry M.D., Hawkins J.B., and Franks A.M. Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure. Am J Health Syst Pharm 64 (2007) 931-936
81. Schwartz A.V., and Sellmeyer D.E. Thiazolidinediones: New evidence of bone loss. J Clin Endocrinol Metab 92 (2007) 1232-1234
82. Nissen S.E., and Wolski K. Effect of Rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007) 2459-2471
83. Becker R.H. Insulin glulisine complementing basal insulins: a review of structure and activity. Diabetes Technol Ther 9 (2007) 109-121
84. Chanterjee S., Tringham J.R., and Davies M.J. Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus. Expert Opin Pharmacother 7 (2006) 1357-1371
85. Peterson G.E. Intermediate and long-acting insulins: A review of NPH insulin, insulin glargine and insulin detemir. Curr Med Res Opin 22 (2006) 2613-2619
86. Gueyffier F., Bulpitt C., Boissel J.P., et al. Antihypertensive drugs in very old people: A subgroup metaanalysis of randomized controlled trials. Lancet 353 (1999) 793-796
87. Bulpitt C.J., Beckett N.S., Cooke J., et al. Hypertension in Very Elderly Trial Working Group. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 21 (2003) 2409-2417
88. Oliner C.M., Elliott W.J., Gretler D.D., and Murphy M.B. Low predictive value of positive Osler manoeuvre for diagnosing pseudohypertension. J Hum Hypertens 7 (1993) 65-70
89. Iwanczyk L., Weintraub N.T., and Rubenstein L.Z. Orthostatic hypotension in the nursing home setting. J Am Med Dir Assoc 7 (2006) 163-167
90. Maurer M.S., Cohen S., and Cheng H. The degree and timing of orthostatic blood pressure changes in relation to falls in nursing home residents. J Am Med Dir Assoc 5 (2004) 233-238
91. Ooi W.L., Hossain M., and Lipsitz L.A. The association between orthostatic hypotension and recurrent falls in nursing home residents. Am J Med 108 (2000) 106-111
92. Ooi W.L., Barrett S., Hossain M., et al. Patterns of orthostatic blood pressure change and their cinical correlates in a frail, elderly population. JAMA 277 (1997) 1299-1304
93. Morley J.E. Postprandial hypotension-the ultimate Big Mac attack [editorial]. J Gerontol A Biol Sci Med Sci 56 (2001) M741-M743
94. Jansen R.W., Kelly-Gagnon M.M., and Lipsitz L.A. Intraindividual reproducibility of postprandial and orthostatic blood pressure changes in older nursing-home patients: Relationship with chronic use of cardiovascular medications. J Am Geriatr Soc 44 (1996) 383-389
95. Edwards B.J., Perry III H.M., Kaiser F.E., et al. Relationship of age and calcitonin gene-related peptide to postprandial hypotension. Mech Ageing Dev 87 (1996) 61-73
96. Gentilcore D., Jones K.L., O'Donovan D.G., and Horowitz M. Postprandial hypotension-novel insights into pathophysiology and therapeutic implications. Curr Vasc Pharmacol 4 (2006) 161-171
97. Vaitkevicius P.V., Esserwein D.M., Maynard A.K., et al. Frequency and importance of postprandial blood pressure reduction in elderly nursing-home patients. Ann Intern Med 115 (1991) 865-870
98. Aronow W.S., and Ahn C. Postprandial hypotension in 499 elderly persons in a long-term health care facility. J Am Geriatr Soc 42 (1994) 930-932
99. Aronow W.S., and Ahn C. Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents. J Am Geriatr Soc 45 (1997) 1051-1053
100. LeCouteur D.G., Fisher A.A., Davis M.W., and McLean A.J. Postprandial systolic blood pressure responses of older people in residential care: Association with risk of falling. Gerontology 49 (2003) 260-264
101. Gentilcore D., Bryant B., Wishart J.M., et al. Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly. Am J Med 118 (2005) 1289
102. Thomas D.R. Anemia and quality of life: Unrecognized and undertreated. J Gerontol A Biol Sci Med Sci 59 3 (2004) 238-241
103. Kamenetz Y., Beloosesky Y., Zelter C., et al. Relationship between routine hematological parameters, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly. Aging Clin Exp Res 10 (1998) 32-38
104. Dharmarajan T.S., Avula S., and Norkus E.P. Anemia increases risk for falls in hospitalized older adults: An evaluation of falls in 362 hospitalized, ambulatory, long-term care, and community patients. J Am Med Dir Assoc 7 5 (2006) 287-293
105. Herndon J.G., Helmick C.G., Sattin R.W., et al. Chronic medical conditions and risk of fall injury events at home in older adults. J Am Geriatr Soc 45 6 (1997) 739-743
106. Steinberg K.E. Anemia and falls. J Am Med Dir Assoc 7 5 (2006) 327
107. Di Fazio I., Franzoni S., Fisoni G.B., Gatti S., Cornali C., and Stofler P.M. Predictive role of single disease and their combination on recovery of balance and gait in disabled elderly patients. J Am Med Dir Assoc 7 (2006) 208-211
108. Chaves P., Ashar T., Guralnik J.M., et al. Looking at the relationship between hemoglobin concentration and previous mobility difficulty in older women: Should the criteria used to define anemia in older people be changed?. J Am Geriatr Soc 50 (2002) 1257-1264
109. Levin A., Singer J., Thompson C.R., et al. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27 (1996) 347-354
110. Wu W.C., Rathore S.S., Wang Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
111. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
112. McClellan W.M., Flanders W.D., Langston R.D., et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol 13 (2002) 1928-1936
113. Cella D. Factors influencing quality of life in cancer patients: Anemia and fatigue. Semin Oncol 25 3 suppl 7 (1998) 43-46
114. Beusterien K.M., Nissenson A.R., Port F.K., Kelly M., Steinwald B., and Ware Jr. J.E. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Amer Soc Nephrol 7 (1996) 763-773
115. Tangalos E.G., Hoggard J.G., Murray A.M., and Thomas D.R. Treatment of kidney disease and anemia in elderly, long-term care residents. J Am Med Dir Assoc 5 4 Suppl (2004) H1-H6
116. Drueke T.B., Locatelli F., Clyne N., et al. CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 20 (2006) 2071-2084
117. Singh A.K., Szczech L., Tang K.L., et al. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 20 (2006) 2085-2098
118. Cody J., Daly C., Campbell M., et al. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev 4 (2006) CD003895
119. Agarwal A.K. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Assoc 7 (2006) S7-S12
120. Robinson B.E. Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc 7 (2006) S3-S6
121. Morley J.E., Kim M.J., Haren M.T., Kevorkian R., and Banks W.A. Frailty and the aging male. Aging Male 8 (2005) 135-140
122. Morley J.E., Perry III H.M., and Miller D.K. Something about frailty. J Gerontol A Biol Sci Med Sci 57 (2002) M698-M704
123. Kleinman K.S., Schweitzer S.U., Perdue S.T., Bleifer K.H., and Abels R.I. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: A double-blind, placebo-controlled trial. Am J Kidney Dis 14 6 (1989) 486-495
124. Roth D., Smith R.D., Schulman G., et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24 5 (1994) 777-784
125. Ganguli A., Singh N.P., and Ahuja N. A comparative study of nandrolone decanoate and erythropoietin on albumin levels, quality of life, and progression of renal disease in Indian predialysis CKD patients. Nephrology Dialysis Transplantation 18 Suppl(4) (2003) 692
126. Lim V.S., DeGowin R.L., Zavala D., et al. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. Ann Intern Med 110 2 (1989) 108-114
127. Teehan B.P. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 18 1 (1991) 50-59
128. Clyne N., and Jogestrand T. Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients. Nephron 60 4 (1992) 390-396
129. Thomas D.R. Anemia: It's all about quality of life. J Am Med Dir Assoc 8 2 (2007) 80-82
130. Thomas D.R. Distinguishing starvation from cachexia. Clin Geriatr Med 18 (2002) 883-892
131. Thomas D.R. Weight loss in older adults. Rev Endocr Metab Disord 6 (2005) 129-136
132. Haddad R.Y., and Thomas D.R. Enteral nutrition and tube feeding: A review of the evidence. Clin Geriatr Med 18 (2002) 867-882
133. Thomas D.R. A prospective, randomized clinical study of adjunctive peripheral parenteral nutrition in adult subacute care patients. J Nutr Health Aging 9 (2005) 321-325
134. Morley J.E., Thomas D.R., and Wilson M.M. Cachexia: Pathophysiology and clinical relevance. Am J Clin Nutr 83 4 (2006) 735-743
135. Thomas D.R. Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26 (2007) 389-399
136. Milne A.C., Potter J., and Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2 (2005) CD003288
137. Wilson M.M., Thomas D.R., Rubenstein L.Z., et al. Appetite assessment: Simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 82 5 (2005) 1074-1081
138. Thomas D.R. Guidelines for the use of orexigenic drugs in long-term care. Nutr Clin Pract 21 1 (2006) 82-87
139. Whitney J., Phillips L., Aslam R., et al. Guidelines for the treatment of pressure ulcers. Wound Repair Regen 14 6 (2006) 663-679
140. Thomas D.R. Management of pressure ulcers. J Am Med Dir Assoc 7 1 (2006) 46-59
141. Thomas D.R. The new F-tag 314: Prevention and management of pressure ulcers. J Am Med Dir Assoc 7 8 (2006) 523-531
142. Reddy M., Gill S.S., and Raohon P.A. Preventing pressure ulcers: A systematic review. JAMA 296 (2006) 974-984
143. DeFloor T., De Bacquer D., and Grypdonck M.H. The effect of various combinations of turning and pressure reducing devices on the incidence of pressure ulcers. Int J Nurs Stud 42 (2005) 37-46
144. Young T. The 30 degree tilt position vs the 90 degree lateral and supine positions in reducing the incidence of non-blanching erythema in a hospital inpatient population: a randomised controlled trial. J Tissue Viability 14 3 (2004) 88 90, 92-96
145. Langer G., Schloemer G., Knerr A., et al. Nutritional interventions for preventing and treating pressure ulcers. Cochrane Database Syst Rev 4 (2003) CD003216
146. Bourdel-Marchasson I., Barateau M., Rondeau V., et al., GAGE Group. A multi-center trial of the effects of oral nutritional supplementation in critically ill older inpatients. Groupe Aquitain Geriatrique d'Evaluation. Nutrition 16 1 (2000) 1-5
147. Bouza C., Saz Z., Munor A., and Amate J.M. Efficacy of advanced dressings in the treatment of pressure ulcers: A systematic review. J Wound Care 14 (2005) 193-199
148. Meaume S., Vallet D., Morere M.N., and Teot L. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care 14 (2005) 411-419
149. Laffan A.M., Ballantoni M.F., and Greenough III W.B. Burden of Clostridium difficile-associated diarrhea in a long-term care facility. J Am Geriatr Soc 54 (2006) 1068-1073
150. Archibald L.K., Banerjee S.N., and Jarvis W.R. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 189 (2004) 1585-1589
151. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostidium difficile. N Engl J Med 353 (2005) 2433-2441
152. Dial S., Delaney J.A., Schneider V., and Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 175 (2006) 745-748
153. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastr 101 (2006) 812-822
154. Bricker E., Garg R., Nelson R., et al. Antibiotic treatment for Clostridium difficile associated diarrhea in adults. Cochrane Database Syst Rev 1 (2005) CD004610
155. McFarland L.V., Elmer E.W., and Surawicz C.M. Breaking the cycle: Treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97 (2002) 1769-1775
156. Musher D.M., Logan N., Hamill R.J., et al. Nitazoxanide for the treatment of clostridium difficile colitis. Clin Infect Dis 43 (2006) 421-427
157. Ouslander J.G., Connell B.R., Bliwise D.L., Endeshaw Y., Griffiths P., and Schnelle J.F. A nonpharmacological intervention to improve sleep in nursing home patients: Results of a controlled clinical trial. J Am Geriatr Soc 54 (2006) 38-47
158. Alessi C.A., Martin J.L., Webber A.P., Cynthia Kim E., Harker J.O., and Josephson K.R. Randomized, controlled trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents. J Am Geriatr Soc 53 (2005) 803-810
159. Richards K.C., Beck C., O'Sullivan P.S., and Shue V.M. Effect of individualized social activity on sleep in nursing home residents with dementia. J Am Geriatr Soc 53 (2005) 1510-1517
160. Mendelson W.B. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 66 (2005) 469-476
161. Glass J., Lanctot K.L., Herrmann N., Sproule B.A., and Busto U.E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331 (2005) 1169
162. Hedner J., Yaeche R., Emilien G., Farr I., and Salinas E. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry 15 (2000) 704-712
163. Ancoli-Israel S., Walsh J.K., Mangano R.M., and Fujimori M. Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects. Prim Care Companion J Clin Psychiatry 1 (1999) 114-120
164. Shaw S.H., Curson H., and Coquelin J.P. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. J Int Med Res 20 (1992) 150-161
165. McCall W.V., Erman M., Krystal A.D., et al. A polysomnography study of eszopiclone in elderly patients with insomnia. Curr Med Res Opin 22 (2006) 1633-1642
166. Scharf M., Erman M., Rosenberg R., et al. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. Sleep 28 (2005) 720-727
167. Roth T., Seiden D., Sainati S., et al. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 7 (2006) 312-318
168. Schneider L.S., Dagerman K., and Insel P.S. Risk of death with atypical antipsychotics drug treatment for dementia. JAMA 294 15 (2005) 1934-1943
169. Schneider L.S., Dagerman K., and Insel P.S. Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14 (2006) 191-210
170. Schneider L.S., Tariot P.N., Dagerman K.S., et al., CATIE-AD Study Group. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 355 (2006) 1525-1538
171. Ballard C., and Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 1 (2006) CD003476
172. Seitz D.P., Gill S.S., and van Zyl L.T. Antipsychotics in the treatment of delirium: A systematic review. J Clin Psychiatry 68 (2007) 11-21
173. Kalisvaart K.J., de Jonghe J.F.M., Oggards M.J., et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. J Am Geriatr Soc 53 (2005) 1658-1666